In-Person Access Only | 8.50 CME Credits & MOC Points
Please read:All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com
Total Health's 2026 Best of ASCO® Memphis Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Annual Meeting review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.
Program Chairs:
Saurin Chokshi, MD (The University of Tennessee Health Science Center)
Karen Winkfield, MD, PhD (Vanderbilt-Ingram Cancer Center)
Conference Agenda
Saturday, August 8, 2026
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
8:40 AM
Colorectal Cancer
Saurin Chokshi, MD | The University of Tennessee Health Science Center
9:10 AM
Non-Colorectal Cancer
Axel Grothey, MD | West Cancer Center
9:40 AM
Equity in Precision Medicine: Are Genomic Tools Widening the Gap?
Alicia Martin, PhD | Massachusetts General Hospital
10:00 AM
Breakfast and Exhibits
10:15 AM
Non-CME Breakfast - Abbvie Elahere - Mirvetuximab Soravtansine: A FRα Targeted ADC for Platinum Resistant Ovarian Cancer
KayLee Steiner | AbbVie
11:00 AM
Prostate Cancer
Patrick Pilié, MD | MD Anderson Cancer Center
11:30 AM
Non-Prostate Cancer
Russell Pachynski, MD | Washington University in St. Louis
12:00 PM
Neuroendocrine Tumors
Lowell Anthony, MD | UK HealthCare
12:20 PM
Ovarian Cancer
Kelly Wilkinson, MD | University of Mississippi Medical Center
12:40 PM
Lunch and Exhibits
12:55 PM
Non-CME Lunch - Abbvie - From Evidence to Action: A Case-Based Approach to Collaborative BCL2-Inhibitor Management in AML
Jigar S. Trivedi, MSc, PharmD, BCOP | Abbvie
1:40 PM
Housekeeping and Survey
1:50 PM
Leukemia
Swapna Thota, MD | The University of Tennessee Health Science Center
2:20 PM
Lymphoma
Ryan Jacobs, MD | Wake Forest University School of Medicine
2:50 PM
Multiple Myeloma
Noura Elsedawy, MBBCh | The University of Tennessee Health Science Center
3:20 PM
Adjourn
Sunday, August 9, 2026
7:30 AM
Coffee and Exhibits
8:00 AM
Program Chair Welcome
8:10 AM
Small Cell Lung Cancer
Bilawal Ahmed, MD | The University of Tennessee Health Science Center
8:40 AM
Non Small Cell Lung Cancer
Jason Porter, MD | West Cancer Center
9:10 AM
The Emerging Role of PD-1 × VEGF Bispecific Antibodies in NSCLC
Jason Porter, MD | West Cancer Center
9:40 AM
Optimizing Care Along the Cancer Continuum
Karen Winkfield, MD, PhD | Vanderbilt University Medical Center
10:00 AM
Breakfast and Exhibits
10:15 AM
Non-CME Breakfast - Natera - Shaping the Future of Precision Medicine
Steven Sorscher | Natera
11:00 AM
Head and Neck Cancer
Jose Monteiro, MD | Emory University
11:30 AM
Sarcomas and Rare Cancers
Richard Riedel, MD | Duke Cancer Institute
12:00 PM
The Rapid Adoption and Integration of AI in Oncology: Provider Trust and Readiness
David Waterhouse, MD, MPH | Oncology Hematology Care
12:30 PM
Lunch and Exhibits
12:45 PM
Non-CME Lunch - Gilead - Gilead - Advance your Practice with an ADC Treatment for Appropriate Patients in 1L mTNBC and Pretreated HR+/HER2- mBC
Monica Forner, MD | Memorial Sloan Kettering Cancer Center
1:30 PM
Survivorship
Humaira Sarfraz, MD | O’Neal Comprehensive Cancer Center
2:00 PM
Early Stage Breast Cancer
Sarah Premji, MD | Sarah Cannon Research Institute
2:30 PM
Metastatic Breast Cancer
Demetria Smith-Graziani, MD, MPH | Emory University
3:00 PM
Adjourn
Agenda Subject To Change. All times are CST.
-
Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.
Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers
Stimulate innovative strategies for new and additional research related to treatment and prevention
Recognize the implications for practice change in both the academic and community practice settings
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 8.50 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 8.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 8.50 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program